Silicon Valley
Jing’s practice is primarily focused on patent and trade secret litigation. Her experience covers a broad range of technologies including small molecules (salts, polymorphs, formulations, and process patents) and biologic drugs, medical devices, diagnostics, software, and semiconductors. She has worked on Hatch Waxman (ANDA) litigation as well as Biologics Price Competition and Innovation Act (BPCIA) cases defending multi-billion-dollar diabetes and cancer drugs from generic/biosimilar challenges. Her clients have ranged from big pharmaceutical companies, to biotechnology companies, to pre-IPO startups, which uniquely positions her to counsel companies at all stages on portfolio strategy. Jing’s extensive background in biosciences, including years of laboratory research experience, serves her clients well in high-stakes matters before the Patent Trial and Appeal Board, U.S. District Courts, and Federal Circuit. Recently, Jing helped defend the validity of all challenged claims in a salt/polymorph patent in an IPR and was instrumental in developing parallel district court cases for a blockbuster diabetes drug.
Alongside her intellectual property practice, Jing has the privilege of using her Federal Circuit experience to represent veterans pro bono in their appeals to the court.
Prior to joining Orrick, Jing served as a judicial law clerk for Judge Raymond T. Chen at the U.S. Court of Appeals for the Federal Circuit and was an associate at a Vault 100 litigation boutique in Washington, D.C. Before law school, Jing was a Marshall Scholar, and she pursued dual graduate degrees in biosciences and policy studies while conducting public policy research in the U.K. and the United States.
Silicon Valley
Jing’s practice is primarily focused on patent and trade secret litigation. Her experience covers a broad range of technologies including small molecules (salts, polymorphs, formulations, and process patents) and biologic drugs, medical devices, diagnostics, software, and semiconductors. She has worked on Hatch Waxman (ANDA) litigation as well as Biologics Price Competition and Innovation Act (BPCIA) cases defending multi-billion-dollar diabetes and cancer drugs from generic/biosimilar challenges. Her clients have ranged from big pharmaceutical companies, to biotechnology companies, to pre-IPO startups, which uniquely positions her to counsel companies at all stages on portfolio strategy. Jing’s extensive background in biosciences, including years of laboratory research experience, serves her clients well in high-stakes matters before the Patent Trial and Appeal Board, U.S. District Courts, and Federal Circuit. Recently, Jing helped defend the validity of all challenged claims in a salt/polymorph patent in an IPR and was instrumental in developing parallel district court cases for a blockbuster diabetes drug.
Alongside her intellectual property practice, Jing has the privilege of using her Federal Circuit experience to represent veterans pro bono in their appeals to the court.
Prior to joining Orrick, Jing served as a judicial law clerk for Judge Raymond T. Chen at the U.S. Court of Appeals for the Federal Circuit and was an associate at a Vault 100 litigation boutique in Washington, D.C. Before law school, Jing was a Marshall Scholar, and she pursued dual graduate degrees in biosciences and policy studies while conducting public policy research in the U.K. and the United States.
Orange County
Before joining Orrick, Ernan served as a law clerk for the Honorable Mary H. Murguia of the U.S. Court of Appeals for the Ninth Circuit and the Honorable David G. Campbell of the U.S. District Court for the District of Arizona.
Ernan earned his law degree from the University of California, Berkeley, School of Law, where he served as Executive Editor on the California Law Review. He also earned a Masters in Advanced International Studies from the Diplomatic Academy of Vienna (Austria) and a B.S. in Justice Studies from Arizona State University.
Orange County
Before joining Orrick, Ernan served as a law clerk for the Honorable Mary H. Murguia of the U.S. Court of Appeals for the Ninth Circuit and the Honorable David G. Campbell of the U.S. District Court for the District of Arizona.
Ernan earned his law degree from the University of California, Berkeley, School of Law, where he served as Executive Editor on the California Law Review. He also earned a Masters in Advanced International Studies from the Diplomatic Academy of Vienna (Austria) and a B.S. in Justice Studies from Arizona State University.
San Francisco
In his practice, Chris has been a first chair trial lawyer with more than 30 years of experience handling high stakes, precedent-setting cases, particularly in the products liability arena. His most recent products liability engagements included serving as trial counsel for a large talc company, including trying to conclusion one of the very first mesothelioma cases against it, and leading a cross-office international and national team defending multiple Chinese companies in a historic MDL. At times, a client asked Chris to lead five or more trial teams in products cases in a single year.
Chris also has acted as national counsel for companies facing thousands of mass tort product liability claims and complex, multiparty class action litigation, and has counseled multinational companies entangled in lengthy, enterprise-threatening litigation and negotiated legal and business solutions involving billions of dollars. He has extensive experience in complex and commercial litigation, ranging from insurance recovery disputes to trade secrets issues, and has significant experience in assisting foreign aerospace companies with international arbitration disputes with first-tier aircraft manufacturers.
Earlier in his career, Chris represented large public companies in mergers, acquisitions, strategic investments and private financings; private companies in initial public offerings; and emerging growth companies in general corporate matters. Chris' transactional experience also offers clients a unique perspective on risk mitigation strategies to avoid costly litigation in the future.
Chris also chaired Orrick’s Risk Management Committee and served on its Operations Team. Prior to joining the firm, Chris was a partner at Clifford Chance and a partner at Brobeck, Phleger & Harrison, where he was a member of the Policy Committee, a member of the Executive Committee, Chair of the Risk Management Committee and Chair of the Hiring Committee.
San Francisco
In his practice, Chris has been a first chair trial lawyer with more than 30 years of experience handling high stakes, precedent-setting cases, particularly in the products liability arena. His most recent products liability engagements included serving as trial counsel for a large talc company, including trying to conclusion one of the very first mesothelioma cases against it, and leading a cross-office international and national team defending multiple Chinese companies in a historic MDL. At times, a client asked Chris to lead five or more trial teams in products cases in a single year.
Chris also has acted as national counsel for companies facing thousands of mass tort product liability claims and complex, multiparty class action litigation, and has counseled multinational companies entangled in lengthy, enterprise-threatening litigation and negotiated legal and business solutions involving billions of dollars. He has extensive experience in complex and commercial litigation, ranging from insurance recovery disputes to trade secrets issues, and has significant experience in assisting foreign aerospace companies with international arbitration disputes with first-tier aircraft manufacturers.
Earlier in his career, Chris represented large public companies in mergers, acquisitions, strategic investments and private financings; private companies in initial public offerings; and emerging growth companies in general corporate matters. Chris' transactional experience also offers clients a unique perspective on risk mitigation strategies to avoid costly litigation in the future.
Chris also chaired Orrick’s Risk Management Committee and served on its Operations Team. Prior to joining the firm, Chris was a partner at Clifford Chance and a partner at Brobeck, Phleger & Harrison, where he was a member of the Policy Committee, a member of the Executive Committee, Chair of the Risk Management Committee and Chair of the Hiring Committee.
Milan
Filippo Cristaldi has extensive experience in M&A transactions, both at national and transnational level, mainly in favour of private equity funds and industrial companies.
Filippo Cristaldi also advises on corporate law and has extensive experience in the field of international contracts.
Before joining Orrick, Filippo Cristaldi has provided consultancy at the Vita Samory, Fabbrini e Associati and, previously, at the Rucellai e Raffaelli, Italian law firms based in Milan.
Milan
Filippo Cristaldi has extensive experience in M&A transactions, both at national and transnational level, mainly in favour of private equity funds and industrial companies.
Filippo Cristaldi also advises on corporate law and has extensive experience in the field of international contracts.
Before joining Orrick, Filippo Cristaldi has provided consultancy at the Vita Samory, Fabbrini e Associati and, previously, at the Rucellai e Raffaelli, Italian law firms based in Milan.
Milan
Attilio brings to the table a wealth of knowledge and a deep understanding of the technology sector, which is critical in today's rapidly evolving business landscape. His practice is primarily focuses on providing expert legal advice on cross-border and domestic mergers and acquisitions (M&A), private equity, and venture capital transactions.
Attilio has a rich history of advising both domestic and multinational companies as well as private equity funds through their most critical and complex M&A and investments transactions. His focus within the dynamic realms of technology industry has positioned him as a go-to legal strategist for companies seeking to navigate the intricate and often disruptive characteristic market shifts of these sectors. His tailored approach ensures that the companies he advises are well-positioned to capitalize on the opportunities presented by their investments and M&A activities, fostering growth, innovation, and competitive advantage in a rapidly evolving business landscape.
In the context of innovation, Attilio’s role as an advisor to VC firms and high-growth technology companies places him at the forefront of investments in the tech industry.
His experience covers a broad spectrum of legal disciplines and is critical in identifying and evaluating potential investment opportunities within the sector, particularly in areas prone to rapid growth and innovation. With a seasoned understanding of market trends and the intricacies of startup development, Attilio advises investors on how to allocate their capital effectively, maximizing potential returns.
He is also extensively experienced at guiding technology companies at all stages of their life cycle and his contributions is invaluable for companies transitioning from seed stage through Series A and B funding rounds and eventually to exit strategies. His guidance encompasses strategic planning, corporate governance, and the navigation of regulatory environments. Startups, with their inherent risks and potential for exponential growth, require nuanced advice to thrive, and Attilio offers tailored counsel to help these companies scale their operations, refine their business models, and attract further investment. His experience is also instrumental in preparing these companies for various exit scenarios, whether through acquisitions, mergers, or initial public offerings (IPOs), ensuring that founders and investors alike realize their ventures' full value.
Milan
Attilio brings to the table a wealth of knowledge and a deep understanding of the technology sector, which is critical in today's rapidly evolving business landscape. His practice is primarily focuses on providing expert legal advice on cross-border and domestic mergers and acquisitions (M&A), private equity, and venture capital transactions.
Attilio has a rich history of advising both domestic and multinational companies as well as private equity funds through their most critical and complex M&A and investments transactions. His focus within the dynamic realms of technology industry has positioned him as a go-to legal strategist for companies seeking to navigate the intricate and often disruptive characteristic market shifts of these sectors. His tailored approach ensures that the companies he advises are well-positioned to capitalize on the opportunities presented by their investments and M&A activities, fostering growth, innovation, and competitive advantage in a rapidly evolving business landscape.
In the context of innovation, Attilio’s role as an advisor to VC firms and high-growth technology companies places him at the forefront of investments in the tech industry.
His experience covers a broad spectrum of legal disciplines and is critical in identifying and evaluating potential investment opportunities within the sector, particularly in areas prone to rapid growth and innovation. With a seasoned understanding of market trends and the intricacies of startup development, Attilio advises investors on how to allocate their capital effectively, maximizing potential returns.
He is also extensively experienced at guiding technology companies at all stages of their life cycle and his contributions is invaluable for companies transitioning from seed stage through Series A and B funding rounds and eventually to exit strategies. His guidance encompasses strategic planning, corporate governance, and the navigation of regulatory environments. Startups, with their inherent risks and potential for exponential growth, require nuanced advice to thrive, and Attilio offers tailored counsel to help these companies scale their operations, refine their business models, and attract further investment. His experience is also instrumental in preparing these companies for various exit scenarios, whether through acquisitions, mergers, or initial public offerings (IPOs), ensuring that founders and investors alike realize their ventures' full value.
Los Angeles; Santa Monica
Los Angeles; Santa Monica
For more than a decade, Nick has guided high-growth companies from inception to exit, advising on formation, financings, mergers and acquisitions, and IPOs while serving as outside general counsel on day-to-day legal matters as they scale.
Leveraging Orrick’s sector-focused approach and legal innovation tools, Nick works with companies across a range of industries, with a focus on disruptive technologies—including fintech, Web3 and blockchain, artificial intelligence, healthcare and biotech, digital media, and consumer products. He also represents top venture capital firms investing in these sectors across equity, debt, and token financings.
Prior to joining Orrick, Nick was a senior counsel at Gunderson Dettmer.
Nick earned his J.D. from Loyola Law School in Los Angeles, where he was Editor-in-Chief of the Loyola of Los Angeles Entertainment Law Review and received the Otto Kaus Award for Excellence in Legal Scholarship.
Before law school, he built a career as a journalist, photographer, and publicist covering music, food, and the arts. A proud Husky, he earned his bachelor’s degree from the University of Washington.
Los Angeles; Santa Monica
Los Angeles; Santa Monica
For more than a decade, Nick has guided high-growth companies from inception to exit, advising on formation, financings, mergers and acquisitions, and IPOs while serving as outside general counsel on day-to-day legal matters as they scale.
Leveraging Orrick’s sector-focused approach and legal innovation tools, Nick works with companies across a range of industries, with a focus on disruptive technologies—including fintech, Web3 and blockchain, artificial intelligence, healthcare and biotech, digital media, and consumer products. He also represents top venture capital firms investing in these sectors across equity, debt, and token financings.
Prior to joining Orrick, Nick was a senior counsel at Gunderson Dettmer.
Nick earned his J.D. from Loyola Law School in Los Angeles, where he was Editor-in-Chief of the Loyola of Los Angeles Entertainment Law Review and received the Otto Kaus Award for Excellence in Legal Scholarship.
Before law school, he built a career as a journalist, photographer, and publicist covering music, food, and the arts. A proud Husky, he earned his bachelor’s degree from the University of Washington.